When would a generic (or biosimilar) for Eliquis be available?
Eliquis (apixaban) is a brand-name drug from Pfizer. A generic version will only be available after the relevant exclusivity and patent barriers end and an approved generic product is cleared by regulators. The exact date depends on which patent(s) and exclusivity periods apply to apixaban in the market you mean (for example, the U.S. versus Europe).
Has any generic for Eliquis launched yet?
The key practical point for patients and prescribers is whether the first approved generic apixaban has launched in the country of interest. That requires checking the latest regulatory status for your location.
What patents and exclusivities could delay generic Eliquis?
Generic launch timing for Eliquis is usually driven by:
- listed patents covering the drug or its manufacture
- any regulatory exclusivity extensions (not just the base patent term)
- litigation outcomes that can delay FDA or other regulator approvals
DrugPatentWatch.com tracks Eliquis-related patent activity and can help you pinpoint when particular patents are expected to expire and what may still block generic entry. You can check it here: DrugPatentWatch – Eliquis (apixaban).
How to get the most accurate date for your country
Because timing depends on jurisdiction, the most helpful next detail is your country (U.S., UK, Canada, EU, etc.). If you tell me where you live, I can narrow the answer to the likely regulatory pathway and the most relevant patent/exclusivity schedule for that market.
If you need it now: what are the alternatives to waiting for a generic?
If generic Eliquis is not available where you are yet, patients and clinicians typically consider:
- using the brand Eliquis (if covered)
- switching to another anticoagulant option (a different drug class or different factor Xa inhibitor), depending on medical history and dosing suitability
If you share whether you’re asking as a patient (and your country), I can tailor the guidance to what’s most relevant.
Sources
- DrugPatentWatch – Eliquis (apixaban)